Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management
JCO Precision Oncology · 2023-09 · (7)
DOI: 10.1200/po.23.00391 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2023-09. Verfasst von Mizuki Nishino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Pneumonia, Immunoconjugates, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Trastuzumab deruxtecan (T-DXd) is an antibody-drug conjugate approved for the treatment of several advanced cancers; however, severe or fatal interstitial lung disease/pneumonitis can occur. We characterized the computed tomography (CT) patterns of T-DXd‒related pneumonitis as a marker for its clinical severity. MATERIALS AND METHODS Ninety patients with advanced cancers who developed T-DXd‒related pneumonitis in two completed single-arm clinical trials were included. Three radiologists independently characterized the CT patterns of pneumonitis at diagnosis, for analyses of those patterns' relationships with clinical severity and pneumonitis outcome. RESULTS T-DXd‒related pneumonitis most commonly presented with cryptogenic organizing pneumonia (COP) pattern, observed in 65 patients (72%), followed by a newly identified COP/hypersensitivity pneumonitis (HP) pattern (13%), acute interstitial pneumonia (AIP)/acute respiratory distress syndrome (ARDS) pattern (11%), and HP pattern (3%). A subset of cases with COP pattern demonstrated an atypical distribution with upper and peripheral lung involvement (6/65; 9%). CT patterns were associated with Common Terminology Criteria for Adverse Events severity grades of pneumonitis, with the AIP/ARDS pattern having higher grades compared with others ( P < .0001). Fatal pneumonitis was more common in the AIP/ARDS pattern than in others ( P = .005). The onset of pneumonitis was earlier in the AIP/ARDS pattern compared with others (median time to onset: at 17.9 v 32.7 weeks of therapy; P = .019). Pneumonitis was treated by withholding T-DXd with or without corticosteroids in most patients (78/90; 87%). CONCLUSION T-DXd‒related pneumonitis most commonly demonstrated a COP pattern, with a subset having an atypical distribution. The AIP/ARDS pattern was indicative of severe, potentially fatal pneumonitis, and requires immediate clinical attention to mitigate serious adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA.
- Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Radiology, UMass Memorial Medical Center, University of Massachusetts Chan Medical School, Worcester, MA.
- Department of Radiology, St Luke's International Hospital, Tokyo, Japan.
- Daiichi Sankyo, Inc, Basking Ridge, NJ.
- AstraZeneca, Gaithersburg, MD.
ORCID-Profile: Mizuki Nishino, Masahiko Kusumoto
Zitieren
APA
Nishino, M., Kusumoto, M., Bankier, A. A., Kurihara, Y., Zhang, L., Rasheed, Z., Meinhardt, G., Arunachalam, M., Taitt, C., Wang, Q., & Powell, C. A. (2023). Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management. JCO Precision Oncology. https://doi.org/10.1200/po.23.00391
Vancouver
Nishino M, Kusumoto M, Bankier AA, Kurihara Y, Zhang L, Rasheed Z, et al. Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management. JCO Precision Oncology. 2023. doi:10.1200/po.23.00391
BibTeX
@article{Nishino2023,
author = {Nishino, Mizuki and Kusumoto, Masahiko and Bankier, Alexander A and Kurihara, Yasuyuki and Zhang, Lin and Rasheed, Zeshaan and Meinhardt, Gerold and Arunachalam, Meena and Taitt, Corina and Wang, Qiang and Powell, Charles A},
title = {Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management},
journal = {JCO Precision Oncology},
year = {2023},
number = {7},
doi = {10.1200/po.23.00391}
}
EUVIMED